Photoprotective Effects of the Combination of Extracts of Rosmarinus Officinalis and Citrus Paradisi (Golite OSP) in a Population from South India: A Case Series
Abstract
Background: The benefits of oral sunscreens are fewer skin reactions and systemic protection compared to topical application. The current case series evaluates the performance of oral sunscreen protection, Golite-OSP, in a South Indian population.
Case Presentation: The current study included 11 patients with hyperpigmentation between 20 to 70 years of age. All patients were prescribed one capsule of Golite OSP daily (100 mg/day) for one month, alongside a moisturizer. Four participants (36.4%) exhibited maximum hyperpigmentation, two (18.2%) had severe hyperpigmentation and five (45.5%) showed medium hyperpigmentation. All patients experienced an improvement in their condition. None faced adverse effects or discontinued the medication.
Conclusion: Golite-OSP is a promising treatment for hyperpigmentation in high-UV areas like South India. It offers efficacy in reducing pigmentation and a favourable safety profile.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health. Reported size: 11 participants or records.
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.